Fundz

Antag Therapeutics Appoints Philip Just Larsen as Chief Executive Officer

PRIVATEMay 21, 2026

Position

Chief Executive Officer

Company

Antag Therapeutics

Philip Just Larsen
CopenhagenBiotechnologyHealth CareTherapeutics

Description

Antag Therapeutics has announced the appointment of Philip Just Larsen MD, PhD as Chief Executive Officer. With over 20 years of experience in metabolic diseases and obesity treatment development, Philip transitions from his role as Chairman of the Board to lead the company's executive team.

Quick answer

Antag Therapeutics Appoints Philip Just Larsen as Chief Executive Officer (May 21, 2026). Antag Therapeutics is based in Copenhagen, Capital Region Of Denmark, Denmark.

Who is the new Chief Executive Officer at Antag Therapeutics?
Antag Therapeutics named Philip Just Larsen Chief Executive Officer, announced May 21, 2026.
What did Antag Therapeutics announce on May 21, 2026?
Antag Therapeutics has announced the appointment of Philip Just Larsen MD, PhD as Chief Executive Officer. With over 20 years of experience in metabolic diseases and obesity treatment development, Philip transitions from his role as Chairman of the Board to lead the company's executive team.
What does Antag Therapeutics do?
Antag Therapeutics is dedicated to advancing personalized and flexible obesity treatment through GIP receptor antagonism.
Where is Antag Therapeutics based?
Antag Therapeutics is based in Copenhagen, Capital Region Of Denmark, Denmark.
Which similar companies made leadership changes around the same time?
Corbus Pharmaceuticals Holdings (May 21, 2026), VistaGen (May 20, 2026), Passkey Therapeutics (May 19, 2026) and Azafaros B.V (May 19, 2026) also announced leadership changes within 45 days of Antag Therapeutics.

Source: Fundz verified event record.

Other recent leadership changes in Therapeutics and Biotechnology

Executive moves at companies in the same sectors within 45 days, from Fundz verified event records.

Who to call at Antag Therapeutics, and when

A new leader at Antag Therapeutics brings new priorities and often new vendors. The first weeks are when they listen.

  • An alert the day Antag Therapeutics raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Antag Therapeutics, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Antag Therapeutics. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Antag Therapeutics

Location

Copenhagen, Capital Region Of Denmark, Denmark

About

Antag Therapeutics is dedicated to advancing personalized and flexible obesity treatment through GIP receptor antagonism. The company focuses on innovative research and development to tackle metabolic diseases. With a commitment to improving health outcomes, Antag aims to transform the diabetes and obesity treatment landscape.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Antag Therapeutics changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Predictive Intelligence
Strategic

ML-powered predictions for Antag Therapeutics's next move

Learn about Strategic plan

Antag Therapeutics changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.